A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.

Completed · Phase 3 · Has a placebo group

Conditions studied: Arthralgia, Bunion, Hallux Valgus, Pain

In brief

The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of tapentadol (CG5503) compared with oxycodone and with placebo in subjects who have had a bunionectomy.

Key facts

Study ID
NCT00613938
Run by
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
People needed
901
Starts
2008-02-01
Expected to finish
2008-10-01
Last updated by the study team
2014-05-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.